
This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, a press release from…
According to the company’s press statement, the approval was based on results from the OlympiA Phase III trial, which suggested…
The DCGI’s nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use…
Through Medical Device Rules, the Centre will be able to keep a quality check on all medical devices available in…
Covaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is…
Stempeucel is used in the treatment of Buerger’s disease
Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma companies can…
The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug In…
The product will be available under the brand name ‘Ledisof’ in India
Indian govt defers FTA talks with EU
Expert panel to meet tomorrow to decide on gelatin versus cellulose Veg or non-veg? Not too far in the future,…